MLANA and neoplasm: Haggerty and colleagues demonstrated that HSP90 inhibitors showed to upregulate the expression of tumor antigens such as Melan-A/MART-1, TPR-2, gp100 and enhance T cell recognition in melanoma cell lines (170).